Trials / Withdrawn
WithdrawnNCT04167111
Pilot Study- Treat to Target Vitamin D in End Stage Renal Disease
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Nebraska · Academic / Other
- Sex
- All
- Age
- 21 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Feasibility of dose adjustment to reach a 6 month 25-hydroxy vitamin D level of 35-50 ng/ml in end stage renal disease patients
Detailed description
Pilot study to test the feasibility of adjusting doses based on a prespecified algorithm to reach a 6 month 25(OH)D level of 35-50 ng/ml in end stage renal disease patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Cholecalciferol | Vitamin D |
Timeline
- Start date
- 2021-05-06
- Primary completion
- 2021-05-06
- Completion
- 2021-05-06
- First posted
- 2019-11-18
- Last updated
- 2024-09-03
Source: ClinicalTrials.gov record NCT04167111. Inclusion in this directory is not an endorsement.